← Evidence map

ArticleOncotarget2014

Metformin and erlotinib synergize to inhibit basal breast cancer.

Ying-Ka Ingar Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25361177